References

  1. Schwartz DA, Loftus EV, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology. 2002;122(4):875-80. PubMed | Google Scholar

  2. Michelassi F, Stella M, Balestracci T, Giuliante F, Marogna P, Block GE. Incidence, diagnosis and treatment of enteric and colorectal fistulae in patients with Crohn's disease. Ann Surg .1993;218(5):660-6. PubMed | Google Scholar

  3. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology. 2010 ;139(4): 1147-55. PubMed | Google Scholar

  4. Bouhnik Y, Panis Y. Prise en charge médico-chirurgicale de la maladie de Crohn fistulisante : traitement médical ou chirurgie? Gastroenterol Clin Biol. 2003 ;27(Suppl 3): S98-103. PubMed | Google Scholar

  5. Régimbeau J, Panis Y, De Parades V, Marteau P, Valleur P. Manifestations ano-périnéales de la maladie de Crohn. Gastroenterol Clin Biol .2000;24(1): 36-47. PubMed | Google Scholar

  6. Poritz LS, Gagliano GA, Mcleod RS, MacRae H, Cohen Z. Surgical management of entero and colocutaneous fistulae in Crohn's disease: 17 years experience. Int J Colorectal Dis. 2004; 19(5): 481-5. PubMed | Google Scholar

  7. Hawker P, Givel JC, Keighley MR, Alexander-Williams J, Allan RN. Management of enterocutaneous fistulae in Crohn's disease. Gut. 1983;24(4): 284-7. PubMed | Google Scholar

  8. Kirsh GM, Hampel N, Shuck JM, Resnick MI. Diagnosis and management of vesicoenteric fistulas. Surg Gynecol Obstet. 1991;173(2): 91-7. PubMed | Google Scholar

  9. Solem CA, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Sandborn WJ. Fistulas to the urinary system in Crohn's disease: clinical features and outcomes. Am J Gastroenterol. 2002;97(9): 2300-5. PubMed | Google Scholar

  10. Andreani SM, Dang HH, Grondona P, Khan AZ, Edwards DP. Rectovaginal fistula in Crohn's disease. Dis Colon Rectum. 2007;50(12): 2215-22. PubMed | Google Scholar

  11. Casadesus D, Villasana L, Sanchez IM, Diaz H, Chavez M, Diaz A. Treatment of rectovaginal fistula: a 5-year review. Aust N Z J Obstet Gynecol. 2006;46(1): 49-51. PubMed | Google Scholar

  12. Ruffolo C, Penninckx F, Van Assche G, Vermeire S, Rutgeerts P, Coremans G et al. Outcome of surgery for rectovaginal fistula due to Crohn's disease. Br J Surg. 2009 ;96(10):1190-5. PubMed | Google Scholar

  13. Pariente B, Bouhnik Y. Maladie de Crohn du grêle. POST'U. 2011: 115-24. PubMed | Google Scholar

  14. Nielsen OH, Munck LK. Drug insight: aminosalicylates for the treatment of IBD. Nat Clin Pract Gastroenterol Hepatol. 2007;4(3):160-70. PubMed | Google Scholar

  15. Nielsen OH, Rogler G, Hahnloser D, Thomsen O. Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol .2009;6(2):92-106. PubMed | Google Scholar

  16. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn's disease: A metaanalysis. Ann Intern Med. 1995;123(2): 132-42. PubMed | Google Scholar

  17. Bressler B, Sands BE. Review article: medical therapy for fistulizing Crohn's disease. Aliment Pharmacol Ther. 2006;24(9):1283-93. PubMed | Google Scholar

  18. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine: a long-term randomized double blind study. N Engl J Med. 1980;302(18): 981-7. PubMed | Google Scholar

  19. Markowitz J, Rosa J, Grancher K, Aiges H, Daum F. Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease. Gastroenterology. 1990;99(5):1347-51. PubMed | Google Scholar

  20. Korelitz BI, Adler DJ, Mendelsohn RA, Sacknoff AL. Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease. Am J Gastroenterol. 1993;88(8): 1198-205. PubMed | Google Scholar

  21. Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci. 1985;30(1): 58-64. PubMed | Google Scholar

  22. Margolin ML, Korelitz BI. Management of bladder fistula in Crohn's disease. J Clin Gastroenterol. 1989;11(4):399-402. PubMed | Google Scholar

  23. Glass RE, Ritchie JK, Lennard-Jones JE, Hawley PR, Todd IP. Internal fistulas in Crohn's disease. Dis Colon Rectum. 1985;28(8):557-61. PubMed | Google Scholar

  24. O'Brien JJ, Bayless TM, Bayless JA. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gastroenterology. 1991;101(1):39-46. PubMed | Google Scholar

  25. Present DH, Lichtiger S. Efficacy of cyclosporine in treatment of fistula of Crohn's disease. Dig Dis Sci. 1994;39(2): 374-80. PubMed | Google Scholar

  26. Mahadevan U, Marion JF, Present DH. Fistula response to methotrexate in Crohn's disease: a case series. Aliment Pharmacol Ther. 2003;18(10):1003-8. PubMed | Google Scholar

  27. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogzand RA et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med .1999;340(18): 1398-405. PubMed | Google Scholar

  28. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med .2004;350(9): 876-85. PubMed | Google Scholar

  29. Sands BE, Blank MA, Patel K, van Deventer SJ. Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study. Clin Gastroenterol Hepatol. 2004;2(10): 912-20. PubMed | Google Scholar

  30. Setakhr V, Seksik P, Treton X, Allez M, Devos M, Laharie D et al. Efficacité des anticorps anti-TNF dans le traitement des fistules entéro-cutanées compliquant la maladie de Crohn. GETAID, SNFGE, Congrès des JFHOD. 2010 (poster).. PubMed | Google Scholar

  31. Zhu YF, Tao GQ, Zhou N, Xiang C. Current treatment of rectovaginal fistula in Crohn's disease. World J Gastroenterol. 2011;17(8): 963-7. PubMed | Google Scholar

  32. Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis. 2010;4(1):7-27. PubMed | Google Scholar

  33. Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S et al. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomized, double blind, double-dummy, multicentre trial. Gut. 2010 ;59(6):752-9. PubMed | Google Scholar